Christopher (Chris) Rowland has over 35 years of successful, results-oriented experience in general management, sales, and marketing within the medical device industry. He has more than 15 years of experience as President and CEO in multicultural business environments. Currently, he serves as Chairman of the Board for two MedTech companies and is an active board member or advisor for five additional MedTech companies.

Chris has a proven track record in revenue growth, realignment, and turnarounds in challenging competitive environments. He has experience in managing small, mid-cap, and large global multinational companies. His significant international experience includes managing organizations in the US and abroad, with several expatriate assignments and as a CEO of US, Israeli, and Chinese-held corporations.

Chris holds over 20 patents that have generated more than $1 billion in revenue. He has a strong history of identifying new opportunities, launching new products, and developing new markets. Previously, he served as CEO or President of companies acquired by Covidien/Medtronic, Teleflex, and a Chinese strategic investor.

Chris earned a B.Sc. in Marketing from Southern Illinois University and completed the Executive Leadership Program at Harvard Business School and the Executive Management Program at Columbia Business School.